Life Sciences Critical Technologies & Commercialization (LSCTC)

The Life Sciences Commercialization Training Program (LSCTP) by OBIO supports Canadian life sciences companies in accelerating commercialization by providing hands-on training, mentorship, and access to funding opportunities.

OBIO®

Overview of the Life Sciences Critical Technologies & Commercialization (LSCTC) program:

The LSCTP, led by the Ontario Bioscience Innovation Organization (OBIO), is designed to help Canadian life sciences and health technology companies navigate the complexities of commercialization. The program focuses on equipping participants with critical skills in business strategy, market entry, regulatory requirements, and funding acquisition. Through expert-led workshops, individualized mentorship, and access to OBIO’s extensive network, participants learn to develop and execute effective go-to-market strategies. The LSCTP aims to bridge the gap between innovation and commercialization by preparing companies to scale and compete globally. The program also connects participants with investors and stakeholders in the life sciences sector to foster meaningful collaborations.

Benefits of the Life Sciences Critical Technologies & Commercialization (LSCTC) program:

Hands-on training in commercialization and market strategy development.
One-on-one mentorship from industry experts and leaders.
Access to OBIOs network of investors, partners, and stakeholders.
Insights into regulatory, marketing, and business challenges in life sciences.
Enhanced readiness for scaling and market entry.

Eligibility criteria of the Life Sciences Critical Technologies & Commercialization (LSCTC) program:

Open to Canadian life sciences and health technology companies.
Applicants must demonstrate a clear commercialization goal and innovation readiness.
Companies at various stages of growth can apply, with a focus on scaling businesses.